A Brief Smoking Cessation Intervention for Heavy Drinking Smokers: Treatment Feasibility and Acceptability

Frontiers in Psychiatry
Aaron C LimLara A Ray

Abstract

Approximately 20-25% of regular smokers report heavy drinking. Abstinent smokers are five times as likely to experience a smoking lapse during drinking episodes. Current efforts seek to improve treatments for this subgroup of heavy-drinking smokers. This study tested the feasibility and acceptability of addressing alcohol use in a brief, single session smoking cessation intervention (SMK+A) compared to smoking cessation counseling only (SMK); these interventions were grounded in a motivational interview framework and included personalized feedback, decisional balance, quit day setting, and tailored skills building (e.g., breathing techniques, coping with urges, dealing with social pressures) to maintain abstinence. Descriptive outcomes included reported helpfulness of intervention skills, readiness to change scores, and feasibility of participant recruitment and retention. We also assessed 7-day point prevalence of smoking cessation, and smoking and drinking reduction at 1-month follow-up. Participants (N = 22) were community-based treatment-seeking daily smokers (≥5 cigarettes/day) who were also heavy drinkers (≥14 drinks/week for men, ≥ 7 drinks/week for women; or ≥5 drinks on one episode in past week for men, ≥4 for women). ...Continue Reading

References

Sep 1, 1991·British Journal of Addiction·T F HeathertonK O Fagerström
May 17, 2000·Drug and Alcohol Dependence·D A Dawson
Dec 12, 2003·Addictive Behaviors·Wayne F Velicer, James O Prochaska
May 3, 2006·Archives of General Psychiatry·Helena Chmura KraemerJerome A Yesavage
Jun 28, 2006·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Marc E MooneyDorothy K Hatsukami
Aug 22, 2006·Journal of General Internal Medicine·Kinsey A McCormickKatharine A Bradley
Oct 3, 2006·Psychopharmacology·Sherry A McKeeStephanie S O'Malley
Oct 13, 2007·Journal of Substance Abuse Treatment·Peter GaritiArthur Alterman
Apr 22, 2008·The Cochrane Database of Systematic Reviews·L F SteadT Lancaster
Aug 22, 2008·Journal of Substance Abuse Treatment·Catherine Theresa Baca, Carolina E Yahne
Oct 8, 2008·Journal of Consulting and Clinical Psychology·Christopher W KahlerRichard A Brown
Dec 9, 2008·American Journal of Public Health·Katherine M DollarKenneth E Leonard
Jun 16, 2009·American Journal of Preventive Medicine·Jennifer B McClureJulie Richards
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Douglas Tc LaiJin-Ling Tang
May 28, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·John R HughesShelly Naud
May 29, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Christopher W KahlerJane Metrik
Nov 3, 2010·Journal of Psychiatric Research·Andrew C LeonHelena C Kraemer
Mar 1, 2012·Journal of the National Medical Association·Matthew J CarpenterAnthony J Alberg
Jun 19, 2012·Alcoholism, Clinical and Experimental Research·Benjamin A TollPaula Celestino
Sep 20, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Kenneth A PerkinsNancy C Jao
Dec 6, 2012·Journal of Psychoactive Drugs·Suneel M Agerwala, Elinore F McCance-Katz
Feb 26, 2013·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Linda Tickle-Degnen
Jan 1, 2013·Health Services Insights·Nicola J RobertsSheree M S Smith
Oct 23, 2014·Alcoholism, Clinical and Experimental Research·Daniel J FridbergAndrea C King
Nov 25, 2014·Journal of Consulting and Clinical Psychology·Benjamin A TollK Michael Cummings
Mar 3, 2015·The Cochrane Database of Systematic Reviews·Nicola Lindson-HawleyRachna Begh
Aug 25, 2015·Journal of Substance Abuse Treatment·Lisa M Fucito, Tess H Hanrahan
Jan 1, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jamie BrownSusan Michie
Nov 23, 2016·Drug and Alcohol Dependence·Hannah CarlinerDeborah S Hasin
Apr 13, 2017·Alcoholism, Clinical and Experimental Research·Christopher W KahlerStephanie S O'Malley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.